In order to explain the difference in clinical outcomes, we sought to examine the expression of EMT and CSC markers which have previously been shown to promote tumour progression.6, 12 EpCAM and SALL4 are established CSC markers absent in normal mature hepatocytes. This evidence concerns the gene SALL4 and neoplasm.